Notice of Change in Application Due Date for RFA-CA-27-005 "Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)"
Notice Number:
NOT-CA-26-020
Key Dates
Release Date:
September 30, 2026
Effective Date:
January 11, 2027
Related Announcements
- August 31, 2026 - Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required). See NOFO RFA-CA-27-005.
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to add a second due date of January 11, 2027 in the Key Dates Section of RFA-CA-27-005 "Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)".
Currently Reads
Part I - Key Dates
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| October 01, 2026 | October 01, 2026 | Not Applicable | March 2027 | May 2027 | July 2027 |
Expiration Date: October 02, 2026
Revised to Read
Part I - Key Dates
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| October 01, 2026 | October 01, 2026 | Not Applicable | March 2027 | May 2027 | July 2027 |
| January 11, 2027 | January 11, 2027 | Not Applicable | June 2027 | August 2027 | December 2027 |
Expiration Date: January 12, 2027
All other aspects of the NOFO remain the same.
Inquiries
Please direct all inquiries to:
NCI GTN Program
National Cancer Institute (NCI)
Telephone: 240-276-5922
Email: [email protected]
Department of Health
and Human Services (HHS)
and Human Services (HHS)
